Inventor · disambiguated record
Marie-Christine Bissery
Also filed as: BISSERY MARIE-CHRISTINE
22 granted patents·22 pending applications·645 citations·filing 1993–2019
96Inventor score
Files withAVENTIS PHARMA SA33RHONE POULENC RORER SA4BISSERY MARIE-CHRISTINE2REGENERON PHARMA1SANOFI AVENTIS1
Top patents by PatentIndex Score
44 records- 0197US5728687AAntitumour compositions containing taxane derivativesRHONE POULENC RORER SA·Filed 1993·Granted Mar 17, 1998·135 cites·9 claims
- 0296US5908835AAnti-tumor compositions containing taxane derivativesRHONE POULENC RORER SA·Filed 1997·Granted Jun 1, 1999·119 cites·5 claims
- 0395US6239167B1Antitumor compositions containing taxane derivativesAVENTIS PHARMA SA·Filed 2000·Granted May 29, 2001·53 cites·9 claims
- 0494US6214863B1Antitumor compositions containing taxane derivativesAVENTIS PHARMA SA·Filed 1999·Granted Apr 10, 2001·80 cites·16 claims
- 0592US6960596B2Composition comprising camptothecin or a comptothecin derivative and a platin derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2002·Granted Nov 1, 2005·33 cites·7 claims
- 0688US6441026B1Antitumor compositions containing taxane derivativesAVENTIS PHARMA SA·Filed 2001·Granted Aug 27, 2002·32 cites·19 claims
- 0786US6545010B2Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2001·Granted Apr 8, 2003·15 cites·16 claims
- 0882US6562834B2Combination comprising camptothecin and a stilbene derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2001·Granted May 13, 2003·16 cites·7 claims
- 0981US8388963B2Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereofVRIGNAUD PATRICIA·Filed 2009·Granted Mar 5, 2013·7 cites·14 claims
- 1080US6403634B1Use of taxoid derivativesAVENTIS PHARMA SA·Filed 2000·Granted Jun 11, 2002·10 cites·8 claims
- 1179US6146663AStabilized nanoparticles which may be filtered under sterile conditionsRHONE POULENC RORER SA·Filed 1997·Granted Nov 14, 2000·76 cites·20 claims
- 1275US7851443B2Combination comprising combretastatin and anticancer agentsAVENTIS PHARMA SA·Filed 2008·Granted Dec 14, 2010·3 cites·7 claims
- 1375US6933320B2Combination comprising combretastatin and anticancer agentsAVENTIS PHARMA SA·Filed 2002·Granted Aug 23, 2005·5 cites·8 claims
- 1474US6503889B2Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2001·Granted Jan 7, 2003·5 cites·5 claims
- 1574US6346543B1Use of a taxoid to treat abnormal cell proliferation in the brainAVENTIS PHARMA SA·Filed 1999·Granted Feb 12, 2002·42 cites·5 claims
- 1668US6664242B2Composition and method comprising CPT-11 and a pyrimidine derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2002·Granted Dec 16, 2003·2 cites·6 claims
- 1763US2006084670A1Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 1861US2007149476A1Combination Comprising Combretastatin and Anticancer AgentsAVENTIS PHARMA SA·Filed 2007·Application pending·0 cites
- 1961US2005226940A1Antitumour compositions containing taxane derivativesAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 2061US2011263522A1Antitumour compositions containing taxane derivativesAVENTIS PHARMA SA·Filed 2011·Application pending·0 cites
- 2160US7994212B2Method of treating cancer with docetaxel and doxorubicinAVENTIS PHARMA SA·Filed 2003·Granted Aug 9, 2011·0 cites·18 claims
- 2259US2005075295A1Combination comprising combretastatin and anticancer agentsAVENTIS PHARMA SA·Filed 2004·Application pending·0 cites
- 2358US7989489B2Method of treating leukemia with docetaxel and vinca alkaloidsAVENTIS PHARMA SA·Filed 2003·Granted Aug 2, 2011·0 cites·8 claims
- 2457US8124650B2Antitumor combinations containing taxane derivatives and epidophyllotoxinsBISSERY MARIE-CHRISTINE·Filed 2003·Granted Feb 28, 2012·0 cites·10 claims
- 2557US8101652B2Antitumour combinations containing taxotere and 5-fluorouracilBISSERY MARIE-CHRISTINE·Filed 2003·Granted Jan 24, 2012·0 cites·10 claims
- 2656US2002197245A1Antitumour compositions containing taxane derivativesAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 2753US6548488B2Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancerAVENTIS PHARMA SA·Filed 2001·Granted Apr 15, 2003·0 cites·8 claims
- 2853US2013184205A1Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereofREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 2953US2019275147A1Antitumour combinations containing a vegf inhibiting agent and irinotecanAVENTIS PHARMA SA·Filed 2019·Application pending·0 cites
- 3053US2006178305A1Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereofAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 3152US2014127202A1Antitumour combinations containing a vegf inhibiting agent and irinotecanAVENTIS PHARMA SA·Filed 2014·Application pending·0 cites
- 3252US2003096789A1Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancerAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 3352US2006128640A1Combination of a taxane and a cyclin-dependent kinaseAVENTIS PHARMA SA·Filed 2006·Application pending·0 cites
- 3452US2002183266A1Combination comprising combretastatin and anticancer agentsAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 3550US6156789AMethod for treating abnormal cell proliferation in the brainRHONE POULENC RORER SA·Filed 1998·Granted Dec 5, 2000·12 cites·14 claims
- 3649US2011054035A1Combination Comprising Combretastatin and Anticancer AgentsAVENTIS PHARMA SA·Filed 2010·Application pending·0 cites
- 3749US2009196869A1Antitumor combinations containing taxane derivativesSANOFI AVENTIS·Filed 2009·Application pending·0 cites
- 3848US2005203170A11,3-Diarylprop-2-en-1-ones, compositions containing them and use thereofAVENTIS PHARMA SA·Filed 2005·Application pending·0 cites
- 3948US2014056996A1Antitumoral combination comprising cabazitaxel and cisplatinAVENTIS PHARMA SA·Filed 2013·Application pending·0 cites
- 4047US2002182204A1Combination of a taxane and a cyclin-dependent kinaseFiled 2002·Application pending·0 cites
- 4146US2003195161A1Composition comprising camptothecin or a camptothecin derivative and a topoisomerase II inhibitor for the treatment of cancerFiled 2001·Application pending·0 cites
- 4246US2004147584A21,3-diarylprop-2-en-1-ones, compositions containing them and use thereofAVENTIS PHARMA SA·Filed 2002·Application pending·0 cites
- 4345US2018153931A1Antitumoral combination comprising cabazitaxel and cisplatinAVENTIS PHARMA SA·Filed 2017·Application pending·0 cites
- 4443US2010160233A1Antitumour combinations containing a vegf inhibiting agent and irinotecanAVENTIS PHARMA SA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marie-Christine Bissery files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →